Dr Vinosh Jegatheesan

Angel Investor

The first dedicated early-stage Deep Tech fund in the MENA region (GCC including KSA and North Africa). The MENA/GCC regions stand out as one of the worlds most vibrant and rapidly expanding economic landscapes, offering an exceptional breeding ground for deep tech innovation and investment. With robust economies, substantial local and foreign capital infusion into the tech sector, and a dynamic corporate ecosystem, this region provides a unique platform for startups to flourish and achieve substantial gains upon exit. Focus on Deep Tech: ABRAs particular focus on deep tech (AI-Driven technologies, Industry 4.0, Blockchain), SaaS solutions including Fintech, AgriTech and ClimateTech is also a consistent feature of the Team’s strategy, avoiding ballooning valuations and technology fads. ABRA Investment strategy is economic cycle proof as we invest in B-to-B with a strong emphasis on sustainable Business model. This is our Fund Manager’s/CIO’s (Simon Tobelem) fifth Deep Tech fund. His last fund made 20 investments; 8 of which saw a successful exit, 10 more of which continue to scale and progress, and only 2 of which failed. Typically in VC, one would expect 80% of investments to FAIL, or just return their investment, and only 20% succeeding. With statistics like this of an 80% SUCCESS rate, Simon displays his unique ability and innate acumen for shrewd VC investment, with a heavy emphasis on active participation in investee companies in order to drive value creation. Moreover, his first fund saw a return of 11 times its money to its investors, and still ranks as one of the top-performing VC funds ever.

Angel Investor

Our focus is to help Founders Go Further. RYSE is one of Europe’s leading healthcare investors with a ground-breaking approach to selecting and rapidly scaling innovative early-stage companies. Our investor partnerships - with the largest health-tech accelerator in Europe - and with Novartis, Medtronic, and the NHS, translated great ideas into real-world solutions. Our Dream is to reimagine healthcare to transform 1 billion lives.

Clicks is an app-based game for children with ADHD aimed at improving ADHD diagnosis accuracy and creating efficiency for clinicians. Our app includes a game, an in-app character chatbot and a rewards system to provide diagnostic metrics and behavioural insight to aid in the diagnosis process.

Expansion into Europe can be complex. With over 30 years of experience in direct patient care and support, Sciensus accelerates the process of getting medicines to patients. Through our skilled team of 500 licensed clinical staff, we support over 300,000 patients and partner with over 4,000 hospitals, clinics and pharmacies each year – more than any other European partner. With validated expertise and unparalleled patient access, we’ll help you ensure that your life-changing medicine gets to the right patients at the right time.